Sorafenib vs chemotherapy in the treatment of locally advanced or metastatic, radioactive iodine-refractory differentiated thyroid cancer: real-world data from Turkey.
Majidova N, Aghamaliyeva S, Guliyev M, Dinc G, Akyıldız A, Ozcan E, Akdağ Kahvecıoglu F, Çağrı Yıldırım H, Sever N, Guren AK, Kocaaslan E, Erel P, Agyol Y, Celebi A, Arıkan R, Isık S, Bayoglu IV, Demirci NS, Dizdar Ö, Hacıbekiroğlu I, Kostek O, Sarı M.
Majidova N, et al. Among authors: demirci ns.
J Chemother. 2024 Nov 26:1-6. doi: 10.1080/1120009X.2024.2430845. Online ahead of print.
J Chemother. 2024.
PMID: 39588941